跳至主要内容
临床试验/NCT04118257
NCT04118257已完成不适用

Effects of Short-term Sugary Beverage Consumption on Type-2 Diabetes and Cardiovascular Disease Risk Factors: A Randomized Controlled Trial

Kansas State University2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2017年2月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
2
主要终点
Change in glucose iAUC

研究概览

简要总结

Our goal is to determine how the addition of sugar-sweetened beverages to the diet affects glucose control, cardiovascular disease risk factors, and pulmonary function in healthy, young adults.

详细描述

In a 3-arm randomized controlled trial, 36 participants consumed one of three beverages for three weeks: water (W), caffeine-free soda (S), or 100% fruit juice (FJ). Participants consumed two servings/day (~710mL) of their randomized beverage for three weeks, along with their habitual diets. At baseline and following the 3-week intervention, participants completed glucose control, cardiovascular disease risk factor, and pulmonary function assessments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Free from diagnosis of diabetes and pulmonary illness
  • Have no intake of glucose or lipid lowering medication.

排除标准

  • Currently pregnant
  • Have bronchitis
  • Have more than 2 risk factors for cardiovascular disease, as defined by the American College of Sports Medicine (ACSM).

研究组 & 干预措施

Fruit Juice

Experimental

Participants consumed 2 bottles of 100% fruit juice daily for 3 weeks.

干预措施: Sugary beverage: Fruit juice (Dietary Supplement)

Water

Other

Participants consumed 2 bottles of water daily for 3 weeks.

干预措施: Control: Water (Dietary Supplement)

Soda

Experimental

Participants consumed 2 cans of caffeine-free Coca Cola daily for 3 weeks.

干预措施: Sugary beverage: Soda (Dietary Supplement)

结局指标

主要结局

Change in glucose iAUC

时间窗: Week 0 and Week 3

Glucose obtained from blood sample in a fasted state and in response to a meal

次要结局

  • Change in plasma lipids(Week 0 and Week 3)
  • Change in blood pressure(Week 0 and Week 3)
  • Change in serum fructosamine(Week 0 and Week 3)
  • Change in insulin iAUC(Week 0 and Week 3)
  • Change in homeostatic model assessment for insulin resistance(Week 0 and Week 3)
  • Change in BMI(Week 0 and Week 3)
  • Change in pulmonary function(Week 0 and Week 3)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara K Rosenkranz

Principal Investigator

Kansas State University

研究点 (2)

Loading locations...

相似试验